British Insurer Won’t Pay for Wegovy Weight-Loss Treatment

British private insurer AXA Health has said it will not pay for treatment with Novo Nordisk’s weight-loss drug Wegovy, which launched in the U.K. on Monday. AXA Health told Reuters in a statement: “As it stands, AXA Health would not cover the use of Wegovy as this would be…[#item_full_content]

Related articles

You may also be interested in

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.